Zura Bio Stock
Zura Bio Limited
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- CEO
- Sandeep C. Kulkarni
- Employees
- 40
- Market cap
- $372 M
- IPO
- 21/03/2023
- Web
- zurabio.com
Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and…
Zura Bio stock: price history
1D
-9.3%
1W
-3.0%
1M
-15.8%
6M
-33.2%
YTD
-26.0%
1Y
+13.1%
2Y
-14.3%
5Y
–
10Y
–
Next earnings date
Next earnings date
12/11/2026 (in 26 days)
Volatility around earnings
~151% stronger price swings than usual
Ask the agents about Zura Bio
Analyst assessment of Zura Bio
PRICE TARGET LOW
US$20.00
CONSENSUS
US$20.00
MEDIAN
US$20.00
PRICE TARGET HIGH
US$20.00
1
STRONG BUY
6
BUY
1
HOLD
0
SELL
0
STRONG SELL
8
TOTAL · Buy
As of: 12/08/2026
Zura Bio stock metrics
P/E
-3.43
P/B
2.5
EV/EBITDA
-1.94
RETURN ON EQUITY
-13.3%
NET MARGIN
0.0%
DEBT/EQUITY
0
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
52.5%
FLOAT SHARES
50,356,871
AVG. DAILY VOLUME (30D)
3,027,114
Institutional holders
Comparable stocks
Frequently asked questions about Zura Bio stock
What does Zura Bio do?
Zura Bio Limited is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is Sandeep C. Kulkarni, the company employs around 40 people.
The IPO was on 21/03/2023; the stock trades on NASDAQ under the ticker ZURA.
What do analysts say about Zura Bio stock?
8 analysts rate the stock, the consensus is Buy (as of 12/08/2026).
The average price target is US$20.00, ranging from US$20.00 to US$20.00, with a median of US$20.00.
This is an external assessment, not a statement by Market Jury.
When does Zura Bio report next?
The next earnings date is 12/11/2026.
Around past earnings, price swings were roughly 151% stronger than usual.
Does Zura Bio pay a dividend?
No, Zura Bio currently does not pay a dividend.
Which stocks are comparable to Zura Bio?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
How can I get Zura Bio stock analyzed?
Clicking "Analyze stock" lets five strategies assess Zura Bio against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.